NCBiotech News

We work hard to bring you news about North Carolina’s wide-ranging life sciences community. Please feel free to share it with others. And let us know if you have something we should know about.

NCBiotech awarded 19 grants and loans totaling more than $2.3 million to universities, bioscience companies and nonprofit organizations in the second quarter of its fiscal year.
Surry County seventh graders got to be forensic scientists in a BioNetwork outreach program hosted by the local community college.
Morrisville life sciences professional services organization Kymanox has acquired the European company anteris in a move that expands Kymanox’s reach in the EU.
After receiving a grant from NCBiotech, Appalachian State University assistant professor Michael Reddish, Ph.D., landed a campus record $1.6 million in NIH funding.
RTP's Greenlight Biosciences has received regulatory approval to begin the first phase 1/2 clinical trial of its COVID-19 vaccine candidate in Rwanda.
North Carolina has been recognized by Merchant Maverick as one of the top10 states in the country for women-led startups.
The 20th edition of World Stem Cell Summit will be held in Winston-Salem June 5-9, 2023, in conjunction with the 10th annual Regenerative Medicine Essentials Course.
New York immunotherapy company Immunaeon is the latest firm to establish a presence in Winston-Salem’s growing regenerative medicine community, marketed as the RegenMed Hub.
Winston-Salem is adding three healthcare diagnostics companies and a new clinical trials program to its growing regenerative medicine community, marketed as the RegenMed Hub.
Eva Garland, Jessica Neil and Laura Potter are three outstanding life sciences leaders who are among the 25 awardees of the Triangle Business Journal 2023 Women in Business Awards.
Raleigh biopharma company FLAG Therapeutics has achieved a milestone with an FDA Rare Pediatric Disease designation for the company’s investigational treatment for a rare brain tumor in children.
Ag tech pioneers Calyxt and Cibus have entered into a definitive merger agreement under which they will merge in an all-stock transaction.
RTP-based medical device company Asensus says the expansion of machine vision capabilities to its previously cleared Senhance ISU has just received CE Mark, a European Union regulatory approval for medical devices.
Global pharmaceutical giant Eli Lilly is investing another $450 million and adding at least 100 jobs in an expansion of its nearly completed $474 million Research Triangle Park pharmaceutical manufacturing campus.
Durham pharmaceutical company Eppin Pharma has secured an investment of up to $800,000 from the Male Contraceptive Initiative, a national nonprofit also based in Durham, to help initiate clinical trials for its male birth-control pill.
scroll back to top of page